Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLORE: Neoadjuvant FOLFOX4 and Tomotherapy in Rectal Cancer
NCT02000050Phase 2Completed
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Oct 2013
- Primary completion
- Mar 2019
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in Rectal cancer (RC), sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Started Oct 2013; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
Rectal cancer (RC)
Beyond the preview
Go deeper on NCT02000050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02000050.